Get the Stockscreener App
2.835
2.35%
0.065
Galectin Therapeutics Inc Stock (GALT) Forecast
The Galectin Therapeutics Inc (GALT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.6457, representing a -6.68% decrease from the current price of $2.835. The highest analyst price target is $3.4795, and the lowest is $1.812.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GALT Price Target
Average 1.9873
(-29.90% Downside)
Is Galectin Therapeutics Inc (GALT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.65 | Neutral |
| STOCH(9,6) | 32.02 | Neutral |
| STOCHRSI(14) | 30.16 | Neutral |
| MACD(12,26) | 0.0342 | Sell |
| ADX(14) | 29.48 | Buy |
| William %R | -63.93 | Neutral |
| CCI(14) | 39.20 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.7595
Buy
|
2.7737
Buy
|
| MA20 |
2.7548
Buy
|
2.7497
Buy
|
| MA50 |
2.6952
Buy
|
2.6891
Buy
|
| MA100 |
2.5675
Buy
|
2.6316
Buy
|
| MA200 |
2.6236
Buy
|
2.4815
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, GALT could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on GALT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.65 indicates that GALT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 32.02 indicates that GALT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.16 indicates that GALT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.48 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 39.2 indicates that GALT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GALT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Galectin Therapeutics Inc financial reports and earnings history, Galectin Therapeutics Inc (GALT) stock could reach $2.8785 by 2030, $0.6262 by 2040 and $2.6508 by 2050. See the projected annual prices until 2050 of the Galectin Therapeutics Inc stock below:
- Galectin Therapeutics Inc (GALT) is expected to reach an average price of $0.4648 in 2035, with a high prediction of $0.4648 and a low estimate of $0.1431. This indicates an $-83.61% rise from the last recorded price of $2.835.
- Galectin Therapeutics Inc (GALT) stock is projected to chart a bullish course in 2040, with an average price target of $0.8062, representing an $-71.56% surge from its current level. The forecast ranges from a conservative $0.6011 to a sky-high $0.6262.
- Our analysts predict Galectin Therapeutics Inc (GALT) to jump -30.18% by 2045, soaring from $1.8393 to an average price of $1.9795, potentially reaching $1.8396. While $1.8393 is the low estimate, the potential upside is significant.
- Galectin Therapeutics Inc (GALT) stock is expected to climb by 2050, reaching an average of $2.6967, a $-4.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.6508 and $2.6889, respectively, highlighting the market's uncertainty.
Galectin Therapeutics Inc Stock (GALT) Year by Year Forecast
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2024
Our forecast for GALT stock price in 2024 now indicates an average price target of $2.9292 with a high forecast of $4.2684 and a low forecast of $1.59. The average prediction reflects an increase of +3.32% from the last recorded price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.017 | $1.812 | $3.4795 | -28.85% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2025
Galectin Therapeutics Inc Stock (GALT) is expected to reach an average price of $1.6831 in 2025, with a high prediction of $2.8712 and a low estimate of $0.495. This indicates an -40.63% fall from the last recorded price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.8761 | $1.7036 | $2.1144 | -33.83% |
| February, 2025 | $1.6243 | $1.5529 | $2.0577 | -42.70% |
| March, 2025 | $1.0526 | $0.9426 | $1.891 | -62.87% |
| April, 2025 | $0.9467 | $0.495 | $1.4555 | -66.61% |
| May, 2025 | $0.8199 | $0.6475 | $0.9699 | -71.08% |
| June, 2025 | $1.8432 | $0.9132 | $2.5508 | -34.98% |
| July, 2025 | $1.8673 | $1.5982 | $2.2049 | -34.13% |
| August, 2025 | $1.7806 | $1.5581 | $2.2689 | -37.19% |
| September, 2025 | $1.7338 | $1.4838 | $1.9722 | -38.84% |
| October, 2025 | $1.6679 | $1.5379 | $2.2655 | -41.17% |
| November, 2025 | $1.6912 | $1.4404 | $2.8712 | -40.35% |
| December, 2025 | $1.5653 | $1.4753 | $2.0636 | -44.79% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2026
The predicted value for Galectin Therapeutics Inc (GALT) in 2026 is set at an average of $2.8024. Estimates vary from a peak of $4.7482 to a trough of $0.8567, indicating an -1.15% surge from the present price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.6786 | $1.5162 | $1.8769 | -40.79% |
| February, 2026 | $1.6018 | $1.3218 | $1.9109 | -43.50% |
| March, 2026 | $1.2251 | $1.1553 | $1.6326 | -56.79% |
| April, 2026 | $1.3892 | $0.8567 | $1.7084 | -51.00% |
| May, 2026 | $1.2924 | $1.0708 | $1.5424 | -54.41% |
| June, 2026 | $1.6657 | $1.0557 | $2.3157 | -41.24% |
| July, 2026 | $3.2798 | $1.0965 | $4.7482 | +15.69% |
| August, 2026 | $2.8031 | $2.7431 | $3.6206 | -1.13% |
| September, 2026 | $2.5072 | $1.7072 | $3.4572 | -11.56% |
| October, 2026 | $2.5104 | $1.578 | $2.6104 | -11.45% |
| November, 2026 | $2.9937 | $2.2421 | $3.0237 | +5.60% |
| December, 2026 | $2.9678 | $2.6762 | $3.307 | +4.68% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Galectin Therapeutics Inc (GALT) is $1.6689, with a high forecast of $3.0482 and a low forecast of $0.2897. This indicates an -41.13% decrease from the last price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.361 | $2.181 | $3.0482 | -16.72% |
| February, 2027 | $1.7643 | $1.7143 | $2.4427 | -37.77% |
| March, 2027 | $1.4584 | $1.1484 | $1.8251 | -48.56% |
| April, 2027 | $1.1017 | $1.0509 | $1.55 | -61.14% |
| May, 2027 | $1.2249 | $0.7933 | $1.2849 | -56.79% |
| June, 2027 | $0.904 | $0.839 | $1.2858 | -68.11% |
| July, 2027 | $0.7023 | $0.6823 | $1.0407 | -75.23% |
| August, 2027 | $0.7556 | $0.5947 | $0.8647 | -73.35% |
| September, 2027 | $0.4197 | $0.2897 | $0.8164 | -85.20% |
| October, 2027 | $0.3029 | $0.3029 | $0.8513 | -89.31% |
| November, 2027 | $0.8262 | $0.2937 | $0.8846 | -70.86% |
| December, 2027 | $1.1803 | $0.647 | $1.6786 | -58.37% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2028
In 2028, Galectin Therapeutics Inc (GALT) is projected to reach an average price of $0.8786, with a high projection of $1.6081 and a low estimate of $0.1491. This indicates an -69.01% fall from the last price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9135 | $0.8741 | $1.3611 | -67.78% |
| February, 2028 | $0.7468 | $0.5968 | $1.0152 | -73.66% |
| March, 2028 | $0.5009 | $0.4601 | $0.8284 | -82.33% |
| April, 2028 | $0.4142 | $0.2525 | $0.5617 | -85.39% |
| May, 2028 | $0.3483 | $0.1975 | $0.4588 | -87.72% |
| June, 2028 | $0.2615 | $0.1491 | $0.3499 | -90.78% |
| July, 2028 | $0.8248 | $0.2123 | $1.0248 | -70.91% |
| August, 2028 | $1.0089 | $0.5357 | $1.6081 | -64.41% |
| September, 2028 | $1.2221 | $0.9297 | $1.4013 | -56.89% |
| October, 2028 | $0.8654 | $0.7654 | $1.253 | -69.47% |
| November, 2028 | $0.7195 | $0.6587 | $1.0762 | -74.62% |
| December, 2028 | $0.5928 | $0.432 | $0.7693 | -79.09% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2029
The 2029 price forecast for Galectin Therapeutics Inc Stock (GALT) is $1.9836 on average, with a high prediction of $3.4596 and a low estimate of $0.5077. This represents an -30.03% decrease from the previous price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6569 | $0.5257 | $1.1352 | -76.83% |
| February, 2029 | $0.8128 | $0.5077 | $0.9101 | -71.33% |
| March, 2029 | $0.9234 | $0.7945 | $1.1634 | -67.43% |
| April, 2029 | $1.1767 | $0.8742 | $1.4458 | -58.50% |
| May, 2029 | $1.2708 | $1.1191 | $1.3575 | -55.18% |
| June, 2029 | $1.174 | $0.9716 | $1.2924 | -58.59% |
| July, 2029 | $0.8373 | $0.7323 | $1.2448 | -70.47% |
| August, 2029 | $0.8714 | $0.8081 | $1.1089 | -69.26% |
| September, 2029 | $1.0646 | $0.773 | $1.1046 | -62.45% |
| October, 2029 | $1.6287 | $0.9855 | $1.6686 | -42.55% |
| November, 2029 | $2.562 | $1.4504 | $3.4596 | -9.63% |
| December, 2029 | $2.455 | $2.0728 | $2.9736 | -13.40% |
Galectin Therapeutics Inc Stock (GALT) Price Forecast for 2030
Galectin Therapeutics Inc Stock (GALT) is expected to reach an average price of $1.4717 in 2030, with a high forecast of $2.8785 and a low forecast of $0.0648. This signifies an -48.09% decrease from the last price of $2.835.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5782 | $1.4682 | $2.8785 | -44.33% |
| February, 2030 | $1.9147 | $1.5248 | $2.1314 | -32.46% |
| March, 2030 | $1.2662 | $1.2312 | $1.9663 | -55.34% |
| April, 2030 | $1.2378 | $0.8762 | $1.7429 | -56.34% |
| May, 2030 | $1.571 | $1.1294 | $1.9027 | -44.59% |
| June, 2030 | $1.9524 | $1.5576 | $2.3325 | -31.13% |
| July, 2030 | $1.0607 | $0.9607 | $2.459 | -62.59% |
| August, 2030 | $0.7759 | $0.6872 | $1.2623 | -72.63% |
| September, 2030 | $0.8637 | $0.7305 | $1.0988 | -69.53% |
| October, 2030 | $0.5319 | $0.4819 | $1.0454 | -81.24% |
| November, 2030 | $0.1065 | $0.0648 | $0.7036 | -96.24% |
| December, 2030 | $0.32 | $0.1766 | $0.1117 | -88.71% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):